Diary

Description: 1-day course covering a wide range of licensed and experimental cancer treatments, explaining their mechanism of action at a molecular and cellular level.
Audience: Designed for experienced research nurses, junior doctors, and clinical trials staff with a biology background.
Level: Advanced
To book, contact: education.events@christie.nhs.uk  (this course is organised by the NCRN)
View the programme

Description: This course gives delegates the knowledge and confidence to discuss targeted cancer treatments with their patients and colleagues. It focuses on targeted treatments for solid tumours, but also includes some content on treatments specifically for haematological cancers.
Audience: Oncology nurses/practitioners and anyone involved in the delivery of clinical trials. This course is aimed at delegates who have at least attended an introductory level course, or who have some knowledge of cell biology.
Level: Intermediate/Advanced
To book, contact: Veronica Sinclair (this course is organised by the NCRN)
View the programme

Description: 1-day course providing an overview of the faulty genes and proteins that drive prostate, kidney, bladder and testicular cancer, and of targeted treatment approaches for these diseases
Audience: Ideal for doctors, research nurses and other oncology staff caring for patients with urological cancers.
Level: Advanced
Book online on the Marsden website
View the programme

Description: 1 day course providing an overview of the cellular and genetic makeup of breast and ovarian cancer and targeted treatments in use and in development
Audience: Designed for research nurses and other staff working on breast and ovarian cancer trials; requires some prior understanding of cancer biology.
Level: Intermediate/advanced
To book, contact: education.events@christie.nhs.uk  (this course is organised by the NCRN)
View the programme

Description: 1-day course introducing the unique cellular and genetic features of haematological cancers and targeted treatment approaches in use and in development
Audience: Designed for research nurses and other staff working on haematological cancer trials; requires some prior understanding of cancer biology
Level: Intermediate/advanced
To book, contact: ann.courtman@nhs.net
View the programme

Description: 1-day course summarising the molecular pathology and targeted treatments for small cell and non-small cell lung cancer. The afternoon will include discussion of patient case studies.
Audience: Ideal for doctors, research nurses and other oncology staff caring for patients with lung cancer
Level: Advanced
Book online on the Marsden website
View the programme

Description: 1-day course providing an overview of the faulty genes and proteins that drive prostate, kidney, bladder and testicular cancer, and of targeted treatment approaches for these diseases
Audience: Ideal for doctors, research nurses and other oncology staff caring for patients with urological cancers.
Level: Advanced
To book, contact: education.events@christie.nhs.uk
View the programme

Description: 1-day course describing the cellular and genetic features of haematological cancers and targeted treatments for these cancers
Audience: doctors and senior nurses working in haematological cancers. Requires some knowledge of immunology.
Level: advanced/expert
Book online on the Marsden website
View the programme

Description: 1-day course describing the molecular mechanisms of action of targeted treatments for solid tumours
Audience: Designed for doctors and senior oncology staff with a biological background. Ideal for junior doctors considering a future in oncology.
Level: Advanced/expert
To book, contact: education.events@christie.nhs.uk
View the programme

Description: 1-day course introducing the science behind licensed targeted treatments for solid tumours
Audience: Cancer nurses or anyone involved in the delivery of cancer clinical trials
Level: Intermediate
To book, contact: education.events@christie.nhs.uk
View the programme

Description: 1-day course describing the cellular and genetic features of haematological cancers and targeted treatments for these cancers
Audience: doctors and senior nurses working in haematological cancers. Requires some knowledge of immunology.
Level: advanced/expert
To book, contact: education.events@christie.nhs.uk
View the programme

Description: 1-day course providing an overview of the cellular and genetic makeup of breast and ovarian cancer, along with information on targeted treatments in use and in development for these cancers. The focus of the course is on treatments such as HER2-inhibitors, PARP inhibitors and angiogenesis inhibitors, rather than on hormone treatments.
Level: Advanced (Designed for doctors, research nurses and other experienced oncology staff working in breast and ovarian cancer)
To book contact: Selina Bell (selina.bell@nihr.ac.uk)
View the programme

Description: Half-day course (1-6pm) summarising the molecular pathology and targeted treatments for small cell and non-small cell lung cancer
Audience: Ideal for doctors, research nurses and other oncology staff caring for patients with lung cancer
Level: Advanced
To book, contact: education.events@christie.nhs.uk
View the programme

Description: 2-day course provides a grounding in cancer biology before moving to descriptions of a wide range of targeted treatments for solid tumours. Also includes mechanisms of drug resistance and an introduction to biomarkers and personalised cancer care.
Level: Intermediate (doesn't require any prior scientific knowledge)
To book, contact: education.events@christie.nhs.uk
View the programme

Description: 1-day course describing the faulty genes and proteins that drive colorectal, pancreatic, oesophageal, gastric and primary liver cancer, and an overview of targeted treatments for these diseases.
Level: Advanced
To book, contact: education.events@christie.nhs.uk
View the programme

Description: 1-day course covering a wide range of licensed and experimental cancer treatments, explaining their mechanism of action at a molecular and cellular level. It also contains information on mechanisms of drug resistance and discusses the future of personalised cancer medicine.
Level: Advanced (Designed for doctors, experienced research nurses and other experienced oncology staff)
To book contact: Selina Bell (selina.bell@nihr.ac.uk)
View the programme

Description: 1-day course providing an overview of the cellular and genetic makeup of breast and ovarian cancer, along with information on targeted treatments in use and in development for these cancers. The focus of the course is on treatments such as HER2-inhibitors, PARP inhibitors and angiogenesis inhibitors, rather than on hormone treatments.
Level: Advanced (Designed for doctors, research nurses and other experienced oncology staff working in breast and ovarian cancer)
To book contact: education.events@christie.nhs.uk
View the programme
Full details, and cost information, can be found on the Christie Website

Description: This 2-day course provides a grounding in cancer biology before moving to descriptions of a wide range of targeted treatments for solid tumours. Also includes mechanisms of drug resistance and an introduction to biomarkers and personalised cancer care.
Level: Intermediate (doesn't require any prior scientific knowledge)
To book, contact: education.events@christie.nhs.uk
View the programme

Description: This course provides a broad overview of the cells, genes, proteins and pathways that drive non-small cell lung cancer (NSCLC), prostate cancer and kidney cancer. The course includes the rationale behind many different targeted treatment approaches in use and in development for these cancers, including recent advances in immunotherapies for lung, prostate, kidney and bladder cancer.
Level: Advanced
To book, contact: conferenceteam@rmh.nhs.uk
View the programme
For further information, including costs, visit the Royal Marsden website

Description: This 2-day course provides a grounding in cancer biology before moving to descriptions of a wide range of targeted treatments for solid tumours. Also includes mechanisms of drug resistance and an introduction to biomarkers and personalised cancer care.
Level: Intermediate (doesn't require any prior scientific knowledge)
To book, contact: education.events@christie.nhs.uk
View the programme
Find cost and further booking information on the Christie website

Description: 1-day course describing the faulty genes and proteins that drive colorectal, pancreatic, oesophageal, gastric and primary liver cancer, and an overview of targeted treatments for these diseases.
Level: Advanced
To book, contact: conferenceteam@rmh.nhs.uk
View the programme

For those of you attending this year's NCRI conference in Liverpool, I will be running workshops on Monday and Tuesday morning to de-mystify the scientific content of each day's programme.

My workshops are for people who plan to attend the day's lectures whilst fearing that they won’t understand the relevant scientific concepts.

My workshops will explain words, concepts and ideas, such as:

• Biomarkers and how they relate to personalized medicine
• Epigenetics
• Cancer metabolism
• The ideas behind cancer immunotherapy
• Genetic instability and intra-tumoural heterogeneity
• What we mean by ‘genomics trials’

Similar to previous years’ workshops, I will use diagrams and illustrations to provide clear, easy-to-understand explanations of complicated biological concepts.

The workshops are geared towards non-scientists, such as doctors, nurses, trials staff and patients who’d like to get the most out of this year’s conference.

Description: 1-day course describing the molecular mechanisms of action of targeted treatments for solid tumours
Audience: Designed for doctors and senior oncology staff with a biological background. Ideal for junior doctors considering a future in oncology.
Level: Advanced/expert
To book, contact: conferenceteam@rmh.nhs.uk
View the programme

Description: 1-day course describing the recent advances made in targeted treatments for cancer, using malignant melanoma as the primary example. Delegates will learn about the faulty genes, pathways and proteins that drive malignant melanoma and other solid tumours, and the mechanism of action of targeted treatments such as B-Raf inhibitors and MEK inhibitors. The day also includes an overview of immunotherapy approaches for cancer, including T cell-based treatments and checkpoint inhibitors.
Level: Intermediate
Audience: Ideal for research nurses, clinical nurse specialists, administrative staff, clinical trials coordinators
Cost: £160
To book, contact: conferenceteam@rmh.nhs.uk  or call: 020 7808 2922
View the programme

Description: This course describes the faulty genes, pathways and proteins that drive small cell and non-small cell lung cancer. It also explains the scientific rationale behind targeted treatments in use and in development for these diseases, such as EGFR inhibitors, ALK inhibitors, angiogenesis inhibitors and immunotherapy.
Level: Intermediate/advanced
Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine's other courses
Cost: £150
To book, contact: conferenceteam@rmh.nhs.uk or call: 020 7808 2922
View the programme

Description: 1 day course providing an overview of the cellular and genetic makeup of breast cancer and explains the science behind targeted treatments in use and in development. Includes an overview of hormone treatments and chemotherapy.
Level: Intermediate
Audience: Ideal for research nurses, clinical nurse specialists, administrative staff, clinical trials coordinators
To book, contact: education.events@christie.nhs.uk or call: 0161 446 3403
View the programme

Description: 1-day course describing the cellular and genetic features of haematological cancers and targeted treatments for these cancers
Level: Advanced
Audience: Ideal for research nurses, pharmacists, pharmaceutical companies, junior doctors or anyone who has been on one of my other courses

Cost: £150
To book, contact: conferenceteam@rmh.nhs.uk or call: 020 7808 2922
Book online or view the programme

Description: This 2-day course provides a grounding in cancer biology before moving to descriptions of a wide range of targeted treatments for solid tumours. Also includes mechanisms of drug resistance and an introduction to biomarkers and personalised cancer care.
Level: Intermediate
Audience: Ideal for research nurses, clinical nurse specialists, administrative staff, clinical trials coordinators
To book, contact: education.events@christie.nhs.uk
View the programme

For those of you attending this year's NCRI conference in Liverpool, I will be running workshops on Monday and Tuesday morning to de-mystify the scientific content of each day's programme.

My workshops are for people who plan to attend the day's lectures whilst fearing that they won’t understand the relevant scientific concepts.

My workshops will explain words, concepts and ideas, such as:

• Biomarkers and how they relate to personalized medicine
• Epigenetics
• Cancer metabolism
• The ideas behind cancer immunotherapy
• Genetic instability and intra-tumoural heterogeneity
• What we mean by ‘genomics trials’

Similar to previous years’ workshops, I will use diagrams and illustrations to provide clear, easy-to-understand explanations of complicated biological concepts.

The workshops are geared towards non-scientists, such as doctors, nurses, trials staff and patients who’d like to get the most out of this year’s conference.

Description: 1-day course covering a wide range of licensed and experimental cancer treatments, explaining their mechanism of action at a molecular and cellular level. Treatments described include: growth factor receptor inhibitors, kinase inhibitors, monoclonal antibodies, PARP inhibitors, ALK inhibitors, CDK inhibitors, immunotherapies.
Level: Advanced
Audience: Ideal for pharmacists, scientifically-minded nurses, pharmaceutical companies, junior doctors
To book, contact: conferenceteam@rmh.nhs.uk
View the programme

Description: This course describes the faulty genes, pathways and proteins that drive small cell and non-small cell lung cancer. It also explains the scientific rationale behind targeted treatments in use and in development for these diseases, such as EGFR inhibitors, ALK inhibitors, angiogenesis inhibitors and immunotherapy.
Level: Advanced
Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine's other courses
Cost: £150
To book, contact: conferenceteam@rmh.nhs.uk or call: 020 7808 2922
View an outline of the programme

Description: 1 day course providing an overview of the cellular and genetic makeup of breast cancer and explains the science behind targeted treatments in use and in development. Includes an overview of hormone treatments and chemotherapy.
Level: Intermediate
Audience: Ideal for research nurses, clinical nurse specialists, administrative staff, clinical trials coordinators
To book, contact: education.events@christie.nhs.uk or call: 0161 446 3403
View an outline of the programme

Event: UK Oncology Forum, 2017

Workshop title: Demystifying the science behind cancer immunotherapy

View the full conference programme

Description: An evening course describing the theory behind the new immunotherapy treatments for cancer such as checkpoint inhibitors and CAR T cell therapy
Level: Indermediate/advanced
Audience: Ideal for research nurses, ward nurses, pharmacists, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine's other courses
To book, contact: education.events@christie.nhs.uk or call: 0161 446 3403
View an outline of the programme

Description: This 2-day course provides a grounding in cancer biology before moving to descriptions of a wide range of targeted treatments for solid tumours. Also includes mechanisms of drug resistance and an introduction to biomarkers and personalised cancer care.
Level: Intermediate
Audience: Ideal for research nurses, ward nurses, clinical nurse specialists, administrative staff, clinical trials coordinators
To book, contact: Caroline.Shriver@rmh.nhs.uk

Please note that this course is free for Royal Marsden/ICR staff but £200 for external delegates

View an outline of the programme

Description: This 2-day course provides a grounding in cancer biology before moving to descriptions of a wide range of targeted treatments for solid tumours. Also includes mechanisms of drug resistance and an introduction to biomarkers and personalised cancer care.
Level: Intermediate
Audience: Ideal for research nurses, ward nurses, clinical nurse specialists, administrative staff, clinical trials coordinators
To book, contact: education.events@christie.nhs.uk
View an outline of the programme

For those of you attending this year's NCRI conference in Liverpool, I will be running workshops on Monday and Tuesday morning to explain and unravel the scientific content of each day's programme.

My workshops are for people who plan to attend the day's lectures whilst fearing that they won’t understand the relevant scientific concepts.

My workshops will be tailored according to the topics of the plenary sessions at this year's conference.

Similar to previous years’ workshops, I will use diagrams and illustrations to provide clear, easy-to-understand explanations of complicated biological concepts.

The workshops are geared towards non-scientists, such as doctors, nurses, trials staff and patients who’d like to get the most out of this year’s conference.

View the full conference programme

This FREE evening roadshow combines an introduction to the science behind immunotherapy (presented by Elaine) with the latest advice on the care of patients receiving these treatments from Dr Vicky Coyle and Dr Bode Oladipo.

View the programme

Register to book yourself a place.

View the 'Immunotherapy roadshow' website to view all five events in the series.

This FREE evening roadshow combines an introduction to the science behind immunotherapy (presented by Elaine) with the latest advice on the care of patients receiving these treatments from Dr Janet Graham and Professor Jeff Evans.

View the programme

Register to book yourself a place.

View the 'Immunotherapy roadshow' website to view all five events in the series.

I have partnered with Cancer Research UK to create a FREE online course on the science behind new cancer treatments.

The course is hosted on the FutureLearn website and lasts 5 weeks. Each week there are science videos from me, plus lots of articles and interviews with doctors, nurses and patients.

The course is ideal for anyone who wants to understand targeted cancer treatments in more depth and gain skills in explaining these treatments to patients and colleagues.

Register now

This FREE evening roadshow combines an introduction to the science behind immunotherapy (presented by Elaine) with the latest advice on the care of patients receiving these treatments from Professor Gary Middleton and Dr Neil Steven.

View the programme

Register to book yourself a place.

View the 'Immunotherapy roadshow' website to view all five events in the series.

This FREE evening roadshow combines an introduction to the science behind immunotherapy (presented by Elaine) with the latest advice on the care of patients receiving these treatments from Dr Richard Adams and Professor John Wagstaff.

View the programme

Register to book yourself a place.

View the 'Immunotherapy roadshow' website to view all five events in the series.

This FREE evening roadshow combines an introduction to the science behind immunotherapy (presented by Elaine) with the latest advice on the care of patients receiving these treatments from Dr Mark Tuthill and Dr Miranda Payne.

View the programme

Register to book yourself a place.

View the 'Immunotherapy roadshow' website to view all five events in the series.

Description: 1-day course covering a wide range of licensed and experimental cancer treatments, explaining their mechanism of action at a molecular and cellular level. Treatments described include: growth factor receptor inhibitors, kinase inhibitors, monoclonal antibodies, PARP inhibitors, ALK inhibitors, CDK inhibitors, immunotherapies.
Level: Advanced
Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine’s other courses
Cost: £150
To book, contact: conferenceteam@rmh.nhs.uk
View an outline of the programme

Description: In this course I describe the faulty genes, pathways and proteins that drive small cell and non-small cell lung cancer. I also explain the scientific rationale behind targeted treatments in use and in development for these diseases, such as EGFR inhibitors, ALK and ROS1 inhibitors, B-Raf inhibitors, angiogenesis inhibitors and immunotherapy with checkpoint inhibitors.
Level: Intermediate/Advanced
Audience: Ideal for pharmacists, research nurses, people from pharmaceutical companies, junior doctors or anyone who has been on one of my other courses. Requires a basic understanding of cancer genetics and cancer cell biology.
Cost: TBC
To book, contact: conferenceteam@rmh.nhs.uk or call: 020 7808 2922
View an outline of the programme

Description: In this course I describe the faulty genes, pathways and proteins that drive colorectal, head and neck, pancreatic, oesophageal, gastric and primary liver cancer. I also explain the science behind many targeted treatment approaches for these diseases, including EGFR- and HER2-targeted antibodies, angiogenesis inhibitors and immunotherapy with checkpoint inhibitors.
Level: Intermediate/Advanced
Audience: Ideal for pharmacists, research nurses, people from pharmaceutical companies, junior doctors or anyone who has been on one of my other courses. Requires a basic understanding of cancer genetics and cancer cell biology.
Cost: TBC
To book, contact: conferenceteam@rmh.nhs.uk or call: 020 7808 2922
View an outline of the programme

Description: A half-day course repeated morning and afternoon describing the theory behind the new immunotherapy treatments for cancer such as checkpoint inhibitors (ipilimumab, pembrolizumab, nivolumab, atezolizumab, durvalumab), adoptive cell transfer (CAR T cell therapy, infiltrating T cells), and vaccine-based treatments (peptide and DNA vaccines, oncolytic viruses, dendritic cell vaccines).
Level: Intermediate
Audience: Ideal for anyone with an A level or equivalent understanding of cell biology and genetics and who works with cancer patients, data or treatments.
To book, contact: conferenceteam@rmh.nhs.uk or call: 020 7808 2922
View an outline of the programme

Description: Using a combination of colourful diagrams and clear explanations, I will describe the gene mutations and other defects that drive ovarian cancer (including fallopian tube and other primary peritoneal cancers). I will also examine how this knowledge impacts treatment choice and explain the science behind chemotherapy and PARP, B-Raf and angiogenesis inhibitors. The day will also include the potential of immunotherapy and novel approaches for treatment, screening and patient monitoring.
Level: Intermediate
Audience: Ideal for anyone with an A level or equivalent understanding of cell biology and genetics and who works with cancer patients, data or treatments.
Cost: TBC
To book, contact: conferenceteam@rmh.nhs.uk or call: 020 7808 2922
View an outline of the programme

Description: In this study day I describe the unique cellular and genetic features of haematological cancers and covers a diverse range of targeted treatments for leukaemias, lymphomas and multiple myeloma. Treatments explained include a wide range of monoclonal antibodies, B cell receptor signalling blockers and JAK2, Bcl-2, FLT3 and CDK inhibitors. I also explore the potential of immunotherapy with checkpoint inhibitors and CAR T cells.
Level: Intermediate/Advanced
Audience:Ideal for pharmacists, research nurses, people from pharmaceutical companies, junior doctors or anyone who has been on one of my other courses. Requires a basic understanding of cancer genetics and cancer cell biology.
Cost: TBC
To book, contact: conferenceteam@rmh.nhs.uk or call: 020 7808 2922
View an outline of the programme

This study day is being organised by Amgen.
Elaine will deliver the morning session, covering:

Part 1:
The cellular and genetic make-up of acute lymphoblastic leukaemia (ALL)
• A bit about B cells
• Genetic drivers of ALL
• Clonal evolution & intratumoural heterogeneity
• The role of leukaemic stem cells

Treating Philadelphia Chromosome Positive ALL
• Bcr-Abl inhibitors
• Other treatments

Part 2:
Licensed and novel treatments for ALL
• Blinatumumab
• Inotuzumab ozogamicin
• CAR-modified T cells
• Other treatments in trials

Contact Elaine if you would like to know how to book a place.

View the programme

Elaine will be delivering a plenary session at 9:15am Sunday morning:

Cancer immunotherapy: what’s all the fuss about?

View the full programme

For those of you attending this year's NCRI conference in Glasgow, I will be running workshops on Monday and Tuesday morning to explain and unravel the scientific content of each day's programme.

My workshops are for people who plan to attend the day's lectures whilst fearing that they won’t understand the relevant scientific concepts.

My workshops will be tailored according to the topics of the plenary sessions at this year's conference.

Similar to previous years’ workshops, I will use diagrams and illustrations to provide clear, easy-to-understand explanations of complicated biological concepts.

The workshops are geared towards non-scientists, such as doctors, nurses, trials staff and patients who’d like to get the most out of this year’s conference.

View the full conference programme

Description: 1-day course covering a wide range of licensed and experimental cancer treatments, explaining their mechanism of action at a molecular and cellular level. Treatments described include: growth factor receptor inhibitors, kinase inhibitors, monoclonal antibodies, PARP inhibitors, ALK inhibitors, CDK inhibitors, immunotherapies.
Level: Advanced
Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine’s other courses
Cost: £150
To book, contact: conferenceteam@rmh.nhs.uk
View an outline of the programme

Description: In this course I describe the faulty genes, pathways and proteins that drive colorectal, head and neck, pancreatic, oesophageal, gastric and primary liver cancer. I also explain the science behind many targeted treatment approaches for these diseases, including EGFR- and HER2-targeted antibodies, angiogenesis inhibitors and immunotherapy with checkpoint inhibitors.
Level: Intermediate/Advanced
Audience: Ideal for pharmacists, research nurses, people from pharmaceutical companies, junior doctors or anyone who has been on one of my other courses. Requires a basic understanding of cancer genetics and cancer cell biology.
Cost: £150
To book, contact: conferenceteam@rmh.nhs.uk or call: 020 7808 2922
View an outline of the programme

Description: A half-day course repeated morning and afternoon describing the theory behind the new immunotherapy treatments for cancer such as checkpoint inhibitors (ipilimumab, pembrolizumab, nivolumab, atezolizumab, durvalumab), adoptive cell transfer (CAR T cell therapy, infiltrating T cells), and vaccine-based treatments (peptide and DNA vaccines, oncolytic viruses, dendritic cell vaccines).
Level: Intermediate
Audience: Ideal for anyone with an A level or equivalent understanding of cell biology and genetics and who works with cancer patients, data or treatments.
To book, contact: conferenceteam@rmh.nhs.uk or call: 020 7808 2922
View an outline of the programme

Description: In this study day I describe the unique cellular and genetic features of haematological cancers and covers a diverse range of targeted treatments for leukaemias, lymphomas and multiple myeloma. Treatments explained include a wide range of monoclonal antibodies, B cell receptor signalling blockers and JAK2, Bcl-2, FLT3 and CDK inhibitors. I also explore the potential of immunotherapy with checkpoint inhibitors and CAR T cells.
Level: Intermediate/Advanced
Audience:Ideal for pharmacists, research nurses, people from pharmaceutical companies, junior doctors or anyone who has been on one of my other courses. Requires a basic understanding of cancer genetics and cancer cell biology.
Cost: £150
To book, contact: conferenceteam@rmh.nhs.uk or call: 020 7808 2922
View an outline of the programme

Description: Using a combination of colourful diagrams and clear explanations, I will describe the gene mutations and other defects that drive ovarian cancer (including fallopian tube and other primary peritoneal cancers). I will also examine how this knowledge impacts treatment choice and explain the science behind chemotherapy and PARP, B-Raf and angiogenesis inhibitors. The day will also include the potential of immunotherapy and novel approaches for treatment, screening and patient monitoring.
Level: Intermediate
Audience: Ideal for anyone with an A level or equivalent understanding of cell biology and genetics and who works with cancer patients, data or treatments.
Cost: £150
To book, contact: conferenceteam@rmh.nhs.uk or call: 020 7808 2922
View an outline of the programme

I will be setting the scene with the science behind CAR-modified T cell therapy as part of a comprehensive day on the history, practicalities and realities of this novel treatment approach. To make enquires about the day contact: meetings@hartleytaylor.co.uk

This is a FREE 5-week, online course written and co-presented by Elaine on behalf of Cancer Research UK and hosted on the FutureLearn website.

It will be running again from Monday 21 October.

Click here to sign-up on the FutureLearn website.

Well over 1,000 people have undertaken the course so far. It contains a mixture of videos and articles that explain the science behind cancer treatments such as kinase inhibitors, monoclonal antibodies and immunotherapies. You also hear from cancer nurses, scientists and doctors talking about treatment side effects, the realities of talking to patients, and both the promise and pitfalls of new cancer treatments and biomarkers.

The course is ideal for anyone new to delivering targeted cancer treatments or immunotherapies to cancer patients.

For those of you attending this year's NCRI conference in Glasgow, I will be running workshops on Monday and Tuesday morning to explain and unravel the scientific content of each day's programme.

My workshops are for people who plan to attend the day's lectures whilst fearing that they won’t understand the relevant scientific concepts.

My workshops will be tailored according to the topics of the plenary sessions at this year's conference.

Similar to previous years’ workshops, I will use diagrams and illustrations to provide clear, easy-to-understand explanations of complicated biological concepts.

The workshops are geared towards non-scientists, such as doctors, nurses, trials staff and patients who’d like to get the most out of this year’s conference.

View the full conference programme

Description: This is a one-day course in which I describe the science behind a wide range of licensed and experimental cancer treatments, explaining their mechanism of action at a molecular and cellular level. Treatments described include: growth factor receptor inhibitors, kinase inhibitors, monoclonal antibodies, PARP inhibitors, ALK inhibitors, CDK inhibitors, immunotherapy with checkpoint inhibitors.
Level: Intermediate/Advanced
Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine’s other courses
Cost: £150
To book, contact: conferenceteam@rmh.nhs.uk
View the day's programme

Book your place on the Marsden's website

Description: A one-day course on the biology and genetics of malignant melanoma and the science behind the latest treatment approaches. Both BRAF/MEK inhibitors and checkpoint inhibitors will be explained and the latest trial data presented. The day will also include an overview of novel treatments such as antigen and DNA vaccines and other agents in early phase trials.
Level: Intermediate/Advanced
Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine’s other courses
Cost: £150
To book, contact: conferenceteam@rmh.nhs.uk
View the day's programme

Book your place on the Marsden's website

Format: This is a live, virtual event. Each morning’s content is split over three pre-recorded videos of 30-40 minutes each. Elaine will be online throughout both mornings to interact with learners and answer questions in the live Q&A sessions that follow each video. The presentations will be available online for 30 days after the live event.

Description:

The aim of this course, spread over two mornings, is to provide learners with a good, general understanding of the concepts that underlie precision cancer medicine.

The fundamental idea of precision medicine is to offer each cancer patient a treatment approach that is tailored to the unique biology and genetics of their disease. Elaine will explain how far we are able to do this by exploring the features of cancer we can target now, and where we might get to in the future. She will also look at when precision medicine falls down, and why expectations and realities don’t always align.

Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine's other courses
Cost: £50 per morning
To book, contact: conferenceteam@rmh.nhs.uk
View the programme for morning 1
View the programme for morning 2

Format: This is a live, virtual event. Each morning’s content is split over three pre-recorded videos of 30-40 minutes each. Elaine will be online throughout both mornings to interact with learners and answer questions in the live Q&A sessions that follow each video. The presentations will be available online for 30 days after the live event.

Description: Over the course of two mornings, Elaine will guide you through many of the most relevant topics relating to modern systemic treatments for non-small cell lung cancer (NSCLC).
The first morning’s focus is on the gene faults that drive many NSCLCs and on the targeted treatments that exploit these faults, such as inhibitors of EGFR, ALK, ROS1, B-Raf, HER2, MET and RET.
The second morning is about cancer’s relationship with the immune system and on the checkpoint inhibitor group of immunotherapies, which include PD-1, PD-L1 and CTLA-4 targeted antibody therapies.
As ever, Elaine's presentations are full of colourful and enlightening illustrations to help you make sense of scientific concepts. Her descriptions avoid unnecessary jargon and are pitched so that even those with a relatively limited understanding of cell biology are able to understand (if you don't understand the relationship between DNA, genes and proteins, do look this up beforehand).

View the programme for morning 1

View the programme for morning 2

Audience: This content is ideal for research nurses, clinical nurse specialists, pharmacists and clinical trials coordinators. It may also be of interest to other healthcare professionals involved in the diagnosis and treatment of people with lung cancer.

Cost: £50 per morning; the content will be available for 30 days after the event

To book, contact: conferenceteam@rmh.nhs.uk or call: 020 7808 2921

Description:
The aim of this morning's course is to provide an up-to-date overview of targeted treatments and immunotherapies given to people with malignant melanoma. This includes treatment combinations and new approaches currently being investigated in clinical trials.

Elaine's goal is to explain the science that underpins each treatment and to provide learners with a broad understanding of why treatments work well for some patients but not for others.

Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine's other courses
Cost: £50
To book, contact: conferenceteam@rmh.nhs.uk or book online
View the programme

Description:
The aim of this morning's course is to provide an up-to-date overview of targeted treatments and immunotherapies given to people with bowel cancer. This includes EGFR-targeted antibodies, B-Raf & MEK inhibitors, immunotherapies, and treatment combinations currently being investigated in clinical trials.

Elaine's goal is to explain the science that underpins each treatment and to provide learners with a broad understanding of why treatments work well for some patients but not for others.

Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine's other courses
Cost: £50
To book, contact: conferenceteam@rmh.nhs.uk or book online
View the programme

Description: Over the course the morning, Elaine guides you through the scientific concepts that underpin many of the most used targeted cancer treatments for solid tumours.

Elaine begins by describing what we can and can't target, and the mechanisms of action of monoclonal antibodies and small molecules that block kinases. She then looks at the many treatments that block growth factor controlled signalling pathways. Finally, she turns her attention to other targets and to various biomarker tests to select the right approach for each patient.

This morning is the first part of a virtual study day. On Friday 10 December it is followed by “Molecular Mechanisms of Immunotherapies for Solid Tumours”.

Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine's other courses
Cost: £50
To book, contact: conferenceteam@rmh.nhs.uk or book online
View the programme

Description:

The focus of this morning is on cancer’s relationship with the immune system, and how this knowledge is being used to improve the outlook of people with various solid tumours. Elaine focuses much of her attention on the checkpoint inhibitor group of immunotherapies and highlights some of the lessons learned through the hundreds of clinical trials with checkpoint inhibitors that have taken place over the past decade.

In the latter part of the morning Elaine looks at other technologies, such as CAR T cell therapy, vaccine-based treatments and oncolytic viruses.

This morning is the second part of a virtual study day and follows on from “Molecular Mechanisms of Targeted Therapies for Solid Tumours” on Thursday 09 December.

Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine's other courses
Cost: £50
To book, contact: conferenceteam@rmh.nhs.uk or book online
View the programme

Format: This is a live, virtual event. Each morning’s content is split over three pre-recorded videos of 30-40 minutes each. Elaine will be online throughout both mornings to interact with learners and answer questions in the live Q&A sessions that follow each video. The presentations will be available online for 30 days after the live event.

Description:

The aim of this course, spread over two mornings, is to provide learners with a good, general understanding of the biology, genetics and behaviours of many haematological cancers. Elaine also provides an up-to-date overview of modern systemic treatment approaches given to people with various haematological cancers. This includes CAR T cell therapy and other targeted approaches that have come through clinical trials in recent years.

Elaine's goal is to explain the science that underpins each treatment. She also hopes to provide learners with a broad understanding of why treatments work well for some patients but not for others.

Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine's other courses
Cost: £50 per morning
To book, contact: conferenceteam@rmh.nhs.uk

View the programme for morning 1

View the programme for morning 2